Evidence-based indications for post-mastectomy radiation after neoadjuvant chemotherapy for stage II-III breast cancer.

被引：0
|
作者：
Mayadev, J.
Fowble, B.
Einck, J. P.
Kim, D.
McCloskey, S.
Yashar, C. M.
Chen, S. L.
Hwang, S. E.
机构：
[1] Univ Calif Davis, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, La Jolla, CA 92093 USA
[4] Athena Breast Hlth Network, San Francisco, CA USA
[5] Univ Calif Los Angeles, Santa Monica, CA USA
[6] Univ Calif San Diego, San Diego Moores Canc Ctr, La Jolla, CA 92093 USA
[7] Univ Calif Davis, Davis Med Ctr, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 27期
关键词：
D O I：
10.1200/jco.2011.29.27_suppl.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Indications for Post-Mastectomy Radiation Therapy After Neoadjuvant Chemotherapy
    Zamre, Vaishali
    Goel, Arun Kumar
    Sharma, Gopal
    Singh, Dinesh
    [J]. CLINICAL BREAST CANCER, 2018, 18 (05) : E767 - E768
  • [2] Post-mastectomy hypofractionated radiotherapy in stage II and III breast cancer.
    Yadav, B.
    Sharma, S.
    Singh, R.
    Ghoshal, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 92 : S61 - S61
  • [3] Role of Postmastectomy Radiation After Neoadjuvant Chemotherapy in Stage II-III Breast Cancer
    Fowble, Barbara L.
    Einck, John P.
    Kim, Danny N.
    McCloskey, Susan
    Mayadev, Jyoti
    Yashar, Catheryn
    Chen, Steven L.
    Hwang, E. Shelley
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 494 - 503
  • [4] National Utilization of Post-mastectomy Radiation after Neoadjuvant Chemotherapy
    Kantor, O.
    Liederbach, E.
    Winchester, D. J.
    Pesce, C.
    Wang, C.
    Yao, K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S48 - S49
  • [5] Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy
    Kantor, Olga
    Pesce, Catherine
    Singh, Puneet
    Miller, Megan
    Tseng, Jennifer
    Wang, Chi-Hsiung
    Winchester, David J.
    Yao, Katharine
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (06) : 668 - 676
  • [6] Neoadjuvant combination for stage II-III breast cancer
    Bagchi, Sanjit
    [J]. LANCET ONCOLOGY, 2007, 8 (07): : 579 - 579
  • [7] Postmastectomy radiation therapy in Stage II-III breast cancer patients <35 years old treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy
    Garg, AK
    Oh, JL
    Oswald, M
    Huang, E
    Strom, EA
    Perkins, GH
    Meric-Bernstam, F
    Gwyn, K
    Buchholz, TA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S237 - S237
  • [8] The influence of neoadjuvant chemotherapy on breast conserving therapy and post-mastectomy radiation therapy
    Zellars R.C.
    [J]. Current Breast Cancer Reports, 2011, 3 (4) : 220 - 224
  • [9] Postmastectomy Radiation Therapy Improved Locoregional Control in Patients With Clinical Stage II-III Breast Cancer After Neoadjuvant Chemotherapy
    Cao, L.
    Chen, J.
    Xu, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E40 - E41
  • [10] Metformin with neoadjuvant chemotherapy in stage II-III breast cancer: A phase II clinical trial
    Azazy, H. A.
    Gado, N. M.
    Salem, D. A.
    El-Ghamry, W. R.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S323 - S324
12345